[ad_1]
Apple’s June-quarter earnings report isn’t typically one to write home about, but there’s still value to it.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...